IP Library › Assignment 031801/0663
Patent Assignment
Reel/Frame 031801/0663

Merger

Recorded: 2013-12-17 Pages: 30
Assignor
DOV PHARMACEUTICAL, INC.
Executed: 2010-07-20
Assignee
EUTHYMICS BIOSCIENCE, INC.
43 THORNDIKE STREET, SUITE S1-3, CAMBRIDGE, MASSACHUSETTS, 02141
Covered Property (1)
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Patent: 8,877,798 →
Application: 13/887,367 →
Publication: US 2013/0345439
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 17, 2013
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 031801/0414 →
Assignment of Assignor's Interest Dec 17, 2013
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 031801/0867 →
Corrective Assignment to Correct the State for Assignee Previously Recorded on Reel 031801 Frame 0867. Assignor(S) Hereby Confirms the Change from New Jersey to Massachusetts. Dec 27, 2013
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 031996/0881 →
Assignment of Assignor's Interest Oct 28, 2016
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 040512/0162 →
Merger Dec 13, 2017
From: NEUROVANCE, INC.
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 044867/0815 →